HauptMenu

icon_home.gif Startseite
newspaper.gif NewsEin- oder Ausklappen
tree-T.gif Artikel
tree-T.gif Themen
tree-T.gif Artikel Archiv
tree-L.gif Internet News
som_downloads.gif WellnessführerEin- oder Ausklappen
· Fitness & Bewegung
· Bäder & Thermen
· Behandlung & Beratung
· Ernährung
· Wellness-Berufe
· Beauty & Körperpflege
· Sauna
· Wellness-Produkte
· Wellness-Hersteller
· Solarien & Sonnenstudios
· Gesundheit
· Physiotherapie
· Aus- und Weiterbildung
· Reise und Hotel
· gesundes Schlafen
page_white_text.gif InhalteEin- oder Ausklappen
tree-T.gif Testberichte
tree-T.gif Bildergalerie
icon_community.gif CommunityEin- oder Ausklappen
tree-T.gif Benutzer Anmeldung
tree-T.gif Benutzeraccount
tree-L.gif Gästebuch
icon_poll.gif ServiceEin- oder Ausklappen
tree-T.gif Impressum
tree-T.gif FAQ
tree-T.gif Umfragen
tree-T.gif Feedback
tree-T.gif Uns empfehlen
Werbung

FAQs

· Downloads (6)
· UserPunkte (5)
· WebLinks (5)

Gesundheitswesen - Medizin: Increasing Demand for Targeted Therapy is Boosting the Companion Diagnostics Market

Geschrieben am Donnerstag, 13. Juni 2019 von Administrator

Ritika97 schreibt "The global companion diagnostics market is expected to reach USD 6.51 billion by 2022 from USD 2.17 billion in 2016, at a CAGR of 20.1%.

According to the new market research report "Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) - Global Forecast to 2022", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

A companion diagnostic assay is an in vitro diagnostic device (IVD) that is used to identify whether a patient with certain disease could be benefitted by a particular drug through the biomarker assessment. The report analyzes the companion diagnostics market by product & service, technology, indication, end user, and region.

Based on product & service, the assay kits & reagents segment accounted for the largest share in 2016, owing to its wide range of applications in platforms such as PCR, NGS, IHC, and ISH.

The growth of this market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe, and increasing collaborations and partnerships for companion diagnostics test development.

Companion diagnostic assay kits include test panels that enable the detection of biomarker types. Companion diagnostics assays analyze the efficacy of a drug through the detection of disease biomarker activity against that drug. Companion diagnostic assays are operated on various technology platforms such as polymerase chain reaction (PCR), next-generation sequencing (NGS), immunohistochemistry (IHC), and in situ hybridization (ISH). Reagents include components such as staining solutions, acids, bases, buffers, detergents, solutions, and substrates required while performing various companion diagnostic tests. Reagents are products paired to the diagnostic test procedures and have a single-use.

Reimbursement challenges in different regions could limit market growth to a certain extent. Reimbursements for companion diagnostics vary widely across regions and countries. Currently, in most countries, reimbursement is provided only for treatments that offer better clinical results and evidence of performance.

The prominent players in the global companion diagnostics market are Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), QIAGEN N.V. (Netherland), Illumina Inc. (U.S.).

Know more about Companion Diagnostics Market - https://www.marketsandmarkets.com/PressReleases/companion-diagnostics.asp


Login

Benutzername:

Passwort:


Einstellungen



Artikel Bewertung

Ergebnis: 0
Stimmen: 0

Bitte nehmen Sie sich die Zeit und bewerten diesen Artikel:
Excellent
Sehr gut
Gut
Okay
Schlecht

Verwandte Links

Der meistgelesene Artikel zu dem Thema :

die letzten 5 Artikel


Artikel-Archiv

fit und munter ist ein Angebot der LayerMedia, Inc. Mehr Infos zum Unternehmen finden Sie hier.
Wenn Sie an Werbung in fit und munter interessiert sind, so folgen Sie diesem Link
© 1996 - 20116 LayerMedia und deren Content-Lieferanten. Alle Rechte vorbehalten.